The phosphatidylcholine pathway of diacylglycerol formation stimulated by phorbol diesters occurs via phospholipase D activation

FEBS Letters
M C CabotH Chabbott

Abstract

Agonist-induced degradation of phosphatidylcholine (PC) is of interest as this pathway of diacylglycerol (DG) generation may provide added opportunities for the regulation of protein kinase C (PKC). In REF52 cells [3H]myristic acid is preferentially incorporated into PC; this, coupled with the use of [3H]choline, allows for quantitation of both the water-soluble and the lipid products generated when PC is degraded. In cells prelabeled with [3H]choline, TPA stimulated a time-dependent release, into the medium, of choline and not phosphocholine or glycerophosphocholine. Treatment of [3H]myristic acid-labeled cells with either phorbol diesters, sn-1,2-dioctanoylglycerol, or vasopressin elicited the formation of labeled phosphatidate (PA) and DG. The temporal pattern of PC hydrolysis in cells treated with TPA is indicative of a precursor (PA)-product (DG) relationship for an enzymatic sequence initiated by phospholipase D. Adding propranolol, a phosphatidate phosphohydrolase inhibitor, eliminated TPA-induced DG formation, whereas PA generation was unaffected. From these data we conclude that TPA elicits DG formation from PC by the sequential actions of phospholipase D and phosphatidate phosphohydrolase.

References

May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H Chabbott, M C Cabot
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J M BestermanP Cuatrecasas
Jan 1, 1987·The Biochemical Journal·M LiscovitchR J Wurtman
Jan 1, 1985·Journal of Neurochemistry·B Witter, J N Kanfer
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J E NiedelG R Vandenbark
Mar 27, 1980·Nature·D M Salmon, T W Honeyman

❮ Previous
Next ❯

Citations

May 1, 1991·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·C J WelshK McBride
Jul 9, 1991·Biochimica Et Biophysica Acta·P G HolbrookJ W Daly
Aug 19, 1992·Biochimica Et Biophysica Acta·C Huang, M C Cabot
Nov 29, 1994·Biochemical Pharmacology·K NobeK Momose
Nov 17, 1995·Chemico-biological Interactions·K J MistryR K Bhattacharya
Nov 1, 1991·Trends in Pharmacological Sciences·N T ThompsonL G Garland
Oct 1, 1991·Molecular and Biochemical Parasitology·J Arevalo, H J Saz
Aug 1, 1991·Molecular and Cellular Endocrinology·A M Vinggaard, H S Hansen
Jul 1, 1993·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·E W Haeffner
Aug 1, 1995·Cellular Signalling·A AhmedS K Smith
Mar 13, 1990·European Journal of Pharmacology·J SandmannK Löffelholz
Mar 12, 1992·European Journal of Pharmacology·T KomabayashiM Tsuboi
Jan 1, 1989·Progress in Growth Factor Research·G Milligan, M J Wakelam
Aug 28, 1998·Cellular Signalling·J Gomez-Cambronero, P Keire
Jun 3, 1999·Cellular Signalling·T S HayesJ Gomez-Cambronero
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A SeskoB Mossman
Oct 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·J Gomez-Cambronero
Mar 1, 1990·Journal of Neurochemistry·L Gustavsson, E Hansson
Dec 12, 2012·Infection and Immunity·Sarah E Clark, Jeffrey N Weiser
Jan 1, 1997·Annual Review of Biochemistry·W D SingerP C Sternweis
Oct 1, 1989·Biochemical Pharmacology·J M BoeynaemsS Pirotton
Aug 18, 1995·The Journal of Biological Chemistry·D W WaggonerD N Brindley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.